Skip to content

Clinical trials

Completed Pulmonary Embolism trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Embolism Status: Completed Country / region: Russia Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20063
20074
20091
20131
20142
20161
20172
20201
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb4
Bayer3
Daiichi Sankyo3
Pirogov Russian National Research Medical University2
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)1
Eurasian Association of Therapists1
GlaxoSmithKline1
PharmaDiall Ltd.1
Rovi Pharmaceuticals Laboratories1
Ryazan State Medical University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Embolism19
Venous Thrombosis16
Venous Thromboembolism9
Thrombosis5
Thromboembolism3
Arrhythmias, Cardiac2
Atrial Fibrillation2
COVID-192
Cardiovascular Diseases2
Neoplasms2

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.